FDA medical device classification explained for Class I, II and III devices

What FDA medical device classification means

FDA medical device classification is the risk-based system used in the United States to place a device type into Class I, Class II or Class III. The class is not a simple measure of how complex a product looks. It reflects the level of regulatory control the FDA considers necessary to provide reasonable assurance of safety and effectiveness for the device’s intended use.

In practice, classification affects whether a manufacturer may rely on general controls, must meet device-specific special controls, needs a 510(k) premarket notification, may pursue De Novo classification, or must submit a premarket approval application. For regulatory teams, this work should start before design validation, labeling strategy or U.S. submission planning. Intended use, indications for use, technology, risk profile and comparison to legally marketed device types all influence the outcome.

How the three FDA device classes compare

FDA’s current public materials describe the U.S. system as a three-class, risk-based framework established under section 513 of the Federal Food, Drug, and Cosmetic Act. As the device class increases from Class I to Class III, the level of regulatory control generally increases as well.

FDA class	General risk level	Main regulatory controls	Common market pathway impact
Class I	Low to moderate risk	General controls	Many Class I devices are exempt from 510(k), but exemptions are not automatic for every Class I device.
Class II	Moderate to high risk	General controls and special controls	Many Class II devices require 510(k), while some are 510(k)-exempt subject to limitations.
Class III	High risk	General controls and premarket approval controls	PMA is generally required unless a specific rule, order or transitional status provides another route.

General controls include core FDA authorities such as establishment registration, device listing, labeling requirements, records and reports, corrections and removals, medical device reporting and quality system requirements unless an exemption applies. Special controls are usually device-specific and may include performance standards, postmarket surveillance, patient registries, special labeling, premarket data requirements or FDA guidance. PMA controls apply to Class III devices where general and special controls are not enough to provide reasonable assurance of safety and effectiveness.

How to find the classification for a device

The best starting point is not the class label alone, but the FDA classification regulation and product code that match the device’s intended use. FDA explains that most medical devices can be classified by finding a matching description in Title 21 of the Code of Federal Regulations, Parts 862 through 892. FDA also states that more than 1,700 distinct device types are organized into 16 medical specialty panels, including cardiovascular, dental, neurology, ophthalmic, orthopedic and radiology devices.

Start with intended use and indications for use

Two products with similar hardware can land in different regulatory positions if their intended uses differ. A sensor marketed for general wellness tracking may raise different questions than a sensor intended to diagnose, treat or monitor a disease. Before searching FDA databases, define what the product is intended to do, who will use it, where it will be used, and what claims will appear in labeling, advertising and user instructions.

Search by regulation number and product code

The FDA Product Classification Database is designed to identify device names, product codes, regulation numbers, review panels and related regulatory information. FDA says the database files are updated every Sunday, so teams should verify classification information close to the date of a regulatory decision or submission.

The product code deserves particular attention. One regulation number can sometimes include multiple product codes, and those codes may carry different review expectations or exemption status.

Read the full classification regulation

A classification regulation usually provides the generic device description, intended use, class and marketing requirement information. Do not stop after finding a similar device name. Compare the device description, indications, technological characteristics, limitations and any referenced special controls. If the match is uncertain, treat the classification conclusion as a working hypothesis rather than a final regulatory position.

How classification affects 510(k), De Novo and PMA planning

Classification is useful because it connects a device type to a likely U.S. market pathway. It is not, by itself, marketing authorization. A manufacturer still has to satisfy the applicable pathway and postmarket requirements.

When 510(k) may apply

A 510(k) submission is commonly associated with many Class II devices and some Class I devices. The central question is whether the new device can be shown to be substantially equivalent to a legally marketed predicate device. FDA has required most 510(k) submissions, unless exempted, to be submitted electronically using eSTAR since October 1, 2023.

For planning purposes, classification work should cover more than class and product code. It should also include predicate strategy, comparison of technological characteristics and identification of applicable special controls.

When 510(k) exemption may apply

Many Class I devices and some Class II devices are exempt from 510(k), but exemption status must be confirmed for the specific device type and product code. FDA materials also emphasize that a device exempt from 510(k) must still comply with other regulatory controls unless the regulation expressly provides an exemption.

General limitations to exemption are found across the device classification regulations, including 21 CFR 862.9 through 892.9. A significant change in intended use, technology or risk profile can remove a device from the practical scope of an exemption. See also: Implants.

When De Novo may apply

De Novo classification is a pathway for novel device types that do not have a legally marketed predicate but for which general controls, or general and special controls, can provide reasonable assurance of safety and effectiveness. If FDA grants a De Novo request, the new device type is classified into Class I or Class II, a new classification regulation is established, and the device may serve as a predicate for future 510(k) submissions when appropriate. FDA has required De Novo submissions, unless exempted, to use eSTAR since October 1, 2025.

When PMA may apply

Class III devices generally require a PMA application. This category includes devices that support or sustain human life, are of substantial importance in preventing impairment of human health, or may present a potential unreasonable risk of illness or injury when lower levels of control are insufficient. PMA planning is usually more evidence-intensive than 510(k) planning because it focuses on valid scientific evidence supporting safety and effectiveness for the proposed indications.

Common classification mistakes to avoid

Misclassification can lead to delays, unexpected testing needs, labeling revisions or a change in submission route. In many projects, the problem is not the device technology itself but an early assumption that was never checked against the regulation and product code.

• Assuming low complexity means Class I. A simple-looking device can still raise higher regulatory concerns if its intended use affects critical diagnosis, treatment or monitoring.
• Using a competitor’s class without confirming the product code. Similar commercial names can hide different indications, technologies or special controls.
• Ignoring exemption limitations. A 510(k)-exempt device may still need a submission if it exceeds the limitations in the classification regulation.
• Confusing clearance, approval and classification. 510(k) devices are cleared, PMA devices are approved, and De Novo requests are granted. These terms should not be used interchangeably.
• Treating accessories as automatically identical to the parent device. Accessories may have their own classification analysis. FDA noted on August 17, 2026 that it was seeking public comment on a proposed list of existing medical device accessories that may or may not be suitable for distinct Class I classification, with comments due by October 16, 2026.

A practical workflow for regulatory teams

A disciplined classification workflow reduces rework and helps align engineering, clinical, quality and regulatory decisions. Teams can use the following sequence as a planning framework:

1. Write a clear intended use statement and draft indications for use.
2. Identify whether the product meets the U.S. medical device definition and whether it may be a combination product or regulated by another FDA center.
3. Search 21 CFR Parts 862 through 892 and the FDA Product Classification Database for matching descriptions, regulation numbers and product codes.
4. Compare the proposed device with legally marketed devices, including intended use, indications, technology, materials, software functions and risk controls.
5. Confirm whether the device type is 510(k)-exempt, requires 510(k), may fit De Novo, or appears to require PMA.
6. Map applicable general controls, special controls, consensus standards, labeling requirements and quality system obligations.
7. If uncertainty remains, consider FDA interaction options such as a Pre-Submission, a 513(g) request for classification information, or other appropriate communication channels.

As of 2026, quality planning should also account for FDA’s Quality Management System Regulation, which became effective on February 2, 2026 and incorporates ISO 13485:2016 by reference with FDA-specific provisions. Classification does not replace quality system analysis, but it helps define the controls, evidence and submission expectations that the quality system must support.

For additional regulatory context and related medical device policy updates, visit the Regulatory section.

Frequently asked questions

Does FDA medical device classification determine whether a device is approved?

No. Classification determines the level of regulatory control and helps identify the likely market pathway. A Class II device may need 510(k) clearance or may be exempt from 510(k). A novel low- or moderate-risk device may use De Novo. A Class III device generally requires PMA approval.

Are all Class I devices exempt from 510(k)?

No. Many Class I devices are 510(k)-exempt, but not all. Exemption status must be checked in the classification regulation and product code information, and limitations to exemption must be reviewed carefully.

Can a device have the same regulation number but a different product code?

Yes. A regulation number may include more than one product code. Product code selection matters because it can affect review expectations, exemption status, recognized device type and predicate analysis.

What should a company do if classification is unclear?

If internal research does not resolve the question, the company can consider structured FDA interaction. A 513(g) request can seek information about the class of a device and applicable requirements, while a Pre-Submission can help obtain FDA feedback on specific regulatory or testing questions before a marketing submission.

Why does classification matter early in development?

Early classification helps teams plan testing, labeling, clinical evidence, software documentation, quality system activities and submission timing. Waiting until the end of development can expose gaps that are expensive or slow to correct.